3D bioprinting is a form of additive manufacturing that uses cells and biomaterials instead of traditional metals and plastics to create 3D constructs that are functional 3D tissues. With the growth of this exciting technology 3D Technology Ltd. and MedScan3D have joined forces to bring the cutting edge ALLEVI bio-printer from 3D Systems to their Irish customers.
Bioprinting can be applied to several areas including but not limited to regenerative medicine, drug discovery and development and 3D cell culture. There are several different bioprinting technologies that can be used to create 3D tissue models. The most popular methods include extrusion based bioprinting, inkjet-based bioprinting, laser-assisted bioprinting (LAB) and stereolithography (STL).
Each method of 3D bioprinting has its advantages. Combining several techniques in one construct allows for greater flexibility and creativity when creating complex 3D tissue models. With 3D Technology Ltd. playing a leading role in the provision of 3D technology in Ireland its CEO James Wall is excited to launch the ALLEVI bio-printer from their long standing international partners 3D Systems. “The rate of development in 3D printing shows no sign of slowing down, and the new bio-printing solutions from 3D Systems take our product offering to the next level. We are already seeing incredible interest from our customers so we’re looking forward to commencing deliveries.”
As a sister company of 3D Technology Ltd., MedScan3D has established itself as the leading provider of 3D printed anatomical models for medical applications in Ireland. MedScan3D Technical Director Jacqui O’Connor sees a huge amount of benefits for medical sector in Ireland with the launch of the new ALLEVI bioprinter in Ireland. “We are absolutely delighted to be working with 3D Technology Ltd. to bring this cutting-edge equipment to Ireland.”
For more information on the ALLEVI bio-printer from 3D Systems visit https://www.allevi3d.com/